Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/HES-130

Approved

STANDARD

HES-130

Shandong Qidu Pharmaceutical Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: a2dbcbe1ca8d57d9
Company: Shandong Qidu Pharmaceutical Co., Ltd.
Type: Standard

Approval Details

Approval Id: a2dbcbe1ca8d57d9
Drug Approval Philippines Name: HES-130
Product Name: HES-130
Registration Number: DR-XY49045
Brand Name: HES-130
Generic Name: Hydroxyethyl Starch 130/0.4+ Sodium Chloride
Dosage Form: Solution for Injection. (IV)
Dosage Strength: 30 g/ 4.5 g (130/0.4) per 500 mL
Manufacturer: Shandong Qidu Pharmaceutical Co., Ltd.
Importer: Endure Medical, Inc.
Distributor: Endure Medical, Inc.
Issuance Date: 28 June 2024
Expiry Date: 16 April 2029
Pharmacologic Category: Blood Substitute and Plasma Protein Fractions
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

a2dbcbe1ca8d57d9

Type

Standard

Back to Philippines FDA Approvals

HES-130 - Philippines FDA Drug Approval Details